LPC
MIST icon

Lion Point Capital’s Milestone Pharmaceuticals MIST Stock Holding History

Lion Point Capital’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Hold
820,000
– – 5.26% 7
2026
Q1 		$976K Buy
820,000
+65,000
+9% +$114K 5.83% 4
2025
Q4 		$1.53M Buy
755,000
+96,447
+15% +$208K 7.89% 1
2025
Q3 		$1.32M Buy
658,553
+109,747
+20% +$193K 7.48% 2
2025
Q2 		$1.06M Hold
548,806
– – 7.23% 7
2025
Q1 		$439K Sell
548,806
-477,000
-47% -$948K 2.8% 15
2024
Q4 		$2.42M Sell
1,025,806
-628,348
-38% -$1.08M 12.68% 2
2024
Q3 		$2.51M Sell
1,654,154
-686,053
-29% -$998K 5.6% 5
2024
Q2 		$3.09M Buy
2,340,207
+40,000
+2% +$64.3K 5.63% 5
2024
Q1 		$4.12M Buy
2,300,207
+650,000
+39% +$1.06M 2.3% 6
2023
Q4 		$2.76M Buy
1,650,207
+1,200,000
+267% +$3.26M 1.38% 6
2023
Q3 		$1.4M Hold
450,207
– – 0.62% 13
2023
Q2 		$1.28M Buy
450,207
+25,000
+6% +$94.3K 0.58% 13
2023
Q1 		$1.68M Hold
425,207
– – 0.69% 18
2022
Q4 		$2.89M Sell
425,207
-1,132,026
-73% -$5.96M 0.41% 22
2022
Q3 		$11.2M Buy
1,557,233
+608,663
+64% +$4.62M 2.46% 13
2022
Q2 		$5.63M Buy
948,570
+265,000
+39% +$1.63M 0.64% 24
2022
Q1 		$4.39M Buy
+683,570
New +$4.27M 1.02% 22

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Lion Point Capital's MIST Position: Q2 2026 in Review

Lion Point Capital held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 820,000 shares worth $1.1M. The position accounts for 5.26% of the portfolio, ranked #7.

Lion Point Capital first reported a position in MIST in Q1 2022 and has held it in 18 quarters since. The position peaked at $11.2M in Q3 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Lion Point Capital held 820,000 shares of Milestone Pharmaceuticals worth $1.1M as of Q2 2026.
  • Lion Point Capital left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up 5.26% of Lion Point Capital's portfolio in Q2 2026, its #7 holding.
  • Lion Point Capital first reported a position in Milestone Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Lion Point Capital's Milestone Pharmaceuticals position peaked at $11.2M in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Lion Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.